Drug Diversion Monitoring
Solutions that monitor data sources to detect and identify people who should be investigated for potentially diverting drugs.
Subject Expert
Jackson Tate
Research Director
Subject Expert
Jackson Tate
Research Director
Bookmark
Decision Insights
Best in KLAS Category
Report Abstract
Key Findings:
- Bluesight & Protenus Customers Want Continued Development for Advanced Capabilities; Invistics’ Smaller Customer Base Seeing Success with AI
- Invistics & HelioMetrics Performing Well Despite Limited Market Adoption; Imprivata Customers Report Continued Struggles Post-Acquisition
- Despite Advancing Integration, BD Customers Continue to Experience Functionality Challenges
- Protenus Leads in Supporting Customers and Keeping Promises; Bluesight Customers Feel Support Is Declining as Vendor Grows
Log inLog in to see the full dataset.
If you don't have a login, getting started is easy.
Provider Organizations
Fill out our registration form to verify your organization.
HIT Companies
Contact a KLAS representative for plans and pricing.
Performance Data
Overall Score by Product
Products Appearing in Decisions
Overall Score by Question Topic
Provider Facility Size by Product
Provider Facility Type by Product
Current Time Inside Cache Tag Helper: 12/12/2024 4:37:30 AM and Model.SegmentId = 365
Related ReportsView All Reports
Reducing Filters
Unlike sizing filters, reducing filters DO NOT recalculate scores based on the evaluations that meet these requirements. They narrow the list of solutions to show the vendors and solutions that can meet a specific need.
This data is based on interviews with a sample of the firms' recent clients. As a result, it is not necessarily comprehensive of all work a firm may do in this segment.
We require a minimum of 2 confirmations of a service performed in the last 3 years for a solution to qualify.